Global Drugs for Treating Mental Disorders Market Growth (Status and Outlook) 2022-2028

Publisher Name :
Date: 11-Feb-2022
No. of pages: 122

As the global economy mends, the 2021 growth of Drugs for Treating Mental Disorders will have significant change from previous year. According to our (LP Information) latest study, the global Drugs for Treating Mental Disorders market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Drugs for Treating Mental Disorders market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Drugs for Treating Mental Disorders market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Drugs for Treating Mental Disorders market, reaching US$ million by the year 2028. As for the Europe Drugs for Treating Mental Disorders landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Drugs for Treating Mental Disorders players cover Johnson and Johnson, Pfizer, Eli Lilly, and GlaxoSmithKline, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Treating Mental Disorders market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

- Tablets

- Capsule

- Injection

- Solution

- Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

- Antipsychotics

- Antidepressants

- Antianxiety (Anxiolyitcs)

- Anti-Seizure Medications

- Stimulants

- Cognitive Disorders And Dementia

- Sleep Disorder Treatments

- Substance Abuse Treatments

- Hypnosis And Tranquilizers

- Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

- Johnson and Johnson

- Pfizer

- Eli Lilly

- GlaxoSmithKline

- AstraZeneca

- Bristol-Myers Squibb

- Teva Pharmaceutical

- Dr. Reddy's Laboratories

- Apotex Inc.

- Mylan Pharmaceuticals

- Par Pharmaceutical

- Aurobindo Pharma

- Torrent Pharmaceuticals

- Jubilant Lifesciences

- Sun Pharmaceutical

- Sandoz (Novartis)

- Hansoh Pharmaceutical

- WATSON Pharmaceuticals

- Zhejiang Langhua Pharmaceuticals

- Forest Laboratories

- H.Lundbeck A/S

- Amneal Pharmaceuticals

- Hetero Drugs

- Macleods Pharmaceuticals

- Silarx Pharmacueticals

- Hikma Pharmaceuticals

- Lupin Limited

- Prinston Pharmaceutical

- STI Pharma

Global Drugs for Treating Mental Disorders Market Growth (Status and Outlook) 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drugs for Treating Mental Disorders Market Size 2017-2028
2.1.2 Drugs for Treating Mental Disorders Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Drugs for Treating Mental Disorders Segment by Type
2.2.1 Tablets
2.2.2 Capsule
2.2.3 Injection
2.2.4 Solution
2.2.5 Other
2.3 Drugs for Treating Mental Disorders Market Size by Type
2.3.1 Drugs for Treating Mental Disorders Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Drugs for Treating Mental Disorders Market Size Market Share by Type (2017-2022)
2.4 Drugs for Treating Mental Disorders Segment by Application
2.4.1 Antipsychotics
2.4.2 Antidepressants
2.4.3 Antianxiety (Anxiolyitcs)
2.4.4 Anti-Seizure Medications
2.4.5 Stimulants
2.4.6 Cognitive Disorders And Dementia
2.4.7 Sleep Disorder Treatments
2.4.8 Substance Abuse Treatments
2.4.9 Hypnosis And Tranquilizers
2.4.10 Other
2.5 Drugs for Treating Mental Disorders Market Size by Application
2.5.1 Drugs for Treating Mental Disorders Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Drugs for Treating Mental Disorders Market Size Market Share by Application (2017-2022)
3 Drugs for Treating Mental Disorders Market Size by Player
3.1 Drugs for Treating Mental Disorders Market Size Market Share by Players
3.1.1 Global Drugs for Treating Mental Disorders Revenue by Players (2020-2022)
3.1.2 Global Drugs for Treating Mental Disorders Revenue Market Share by Players (2020-2022)
3.2 Global Drugs for Treating Mental Disorders Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drugs for Treating Mental Disorders by Regions
4.1 Drugs for Treating Mental Disorders Market Size by Regions (2017-2022)
4.2 Americas Drugs for Treating Mental Disorders Market Size Growth (2017-2022)
4.3 APAC Drugs for Treating Mental Disorders Market Size Growth (2017-2022)
4.4 Europe Drugs for Treating Mental Disorders Market Size Growth (2017-2022)
4.5 Middle East & Africa Drugs for Treating Mental Disorders Market Size Growth (2017-2022)
5 Americas
5.1 Americas Drugs for Treating Mental Disorders Market Size by Country (2017-2022)
5.2 Americas Drugs for Treating Mental Disorders Market Size by Type (2017-2022)
5.3 Americas Drugs for Treating Mental Disorders Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs for Treating Mental Disorders Market Size by Region (2017-2022)
6.2 APAC Drugs for Treating Mental Disorders Market Size by Type (2017-2022)
6.3 APAC Drugs for Treating Mental Disorders Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drugs for Treating Mental Disorders by Country (2017-2022)
7.2 Europe Drugs for Treating Mental Disorders Market Size by Type (2017-2022)
7.3 Europe Drugs for Treating Mental Disorders Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drugs for Treating Mental Disorders by Region (2017-2022)
8.2 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Type (2017-2022)
8.3 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drugs for Treating Mental Disorders Market Forecast
10.1 Global Drugs for Treating Mental Disorders Forecast by Regions (2023-2028)
10.1.1 Global Drugs for Treating Mental Disorders Forecast by Regions (2023-2028)
10.1.2 Americas Drugs for Treating Mental Disorders Forecast
10.1.3 APAC Drugs for Treating Mental Disorders Forecast
10.1.4 Europe Drugs for Treating Mental Disorders Forecast
10.1.5 Middle East & Africa Drugs for Treating Mental Disorders Forecast
10.2 Americas Drugs for Treating Mental Disorders Forecast by Country (2023-2028)
10.2.1 United States Drugs for Treating Mental Disorders Market Forecast
10.2.2 Canada Drugs for Treating Mental Disorders Market Forecast
10.2.3 Mexico Drugs for Treating Mental Disorders Market Forecast
10.2.4 Brazil Drugs for Treating Mental Disorders Market Forecast
10.3 APAC Drugs for Treating Mental Disorders Forecast by Region (2023-2028)
10.3.1 China Drugs for Treating Mental Disorders Market Forecast
10.3.2 Japan Drugs for Treating Mental Disorders Market Forecast
10.3.3 Korea Drugs for Treating Mental Disorders Market Forecast
10.3.4 Southeast Asia Drugs for Treating Mental Disorders Market Forecast
10.3.5 India Drugs for Treating Mental Disorders Market Forecast
10.3.6 Australia Drugs for Treating Mental Disorders Market Forecast
10.4 Europe Drugs for Treating Mental Disorders Forecast by Country (2023-2028)
10.4.1 Germany Drugs for Treating Mental Disorders Market Forecast
10.4.2 France Drugs for Treating Mental Disorders Market Forecast
10.4.3 UK Drugs for Treating Mental Disorders Market Forecast
10.4.4 Italy Drugs for Treating Mental Disorders Market Forecast
10.4.5 Russia Drugs for Treating Mental Disorders Market Forecast
10.5 Middle East & Africa Drugs for Treating Mental Disorders Forecast by Region (2023-2028)
10.5.1 Egypt Drugs for Treating Mental Disorders Market Forecast
10.5.2 South Africa Drugs for Treating Mental Disorders Market Forecast
10.5.3 Israel Drugs for Treating Mental Disorders Market Forecast
10.5.4 Turkey Drugs for Treating Mental Disorders Market Forecast
10.5.5 GCC Countries Drugs for Treating Mental Disorders Market Forecast
10.6 Global Drugs for Treating Mental Disorders Forecast by Type (2023-2028)
10.7 Global Drugs for Treating Mental Disorders Forecast by Application (2023-2028)

11 Key Players Analysis
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Information
11.1.2 Johnson and Johnson Drugs for Treating Mental Disorders Product Offered
11.1.3 Johnson and Johnson Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Johnson and Johnson Main Business Overview
11.1.5 Johnson and Johnson Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Drugs for Treating Mental Disorders Product Offered
11.2.3 Pfizer Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Drugs for Treating Mental Disorders Product Offered
11.3.3 Eli Lilly Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Eli Lilly Main Business Overview
11.3.5 Eli Lilly Latest Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Drugs for Treating Mental Disorders Product Offered
11.4.3 GlaxoSmithKline Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 GlaxoSmithKline Main Business Overview
11.4.5 GlaxoSmithKline Latest Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Drugs for Treating Mental Disorders Product Offered
11.5.3 AstraZeneca Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 AstraZeneca Main Business Overview
11.5.5 AstraZeneca Latest Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Information
11.6.2 Bristol-Myers Squibb Drugs for Treating Mental Disorders Product Offered
11.6.3 Bristol-Myers Squibb Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Bristol-Myers Squibb Main Business Overview
11.6.5 Bristol-Myers Squibb Latest Developments
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Information
11.7.2 Teva Pharmaceutical Drugs for Treating Mental Disorders Product Offered
11.7.3 Teva Pharmaceutical Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Teva Pharmaceutical Main Business Overview
11.7.5 Teva Pharmaceutical Latest Developments
11.8 Dr. Reddy's Laboratories
11.8.1 Dr. Reddy's Laboratories Company Information
11.8.2 Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Product Offered
11.8.3 Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Dr. Reddy's Laboratories Main Business Overview
11.8.5 Dr. Reddy's Laboratories Latest Developments
11.9 Apotex Inc.
11.9.1 Apotex Inc. Company Information
11.9.2 Apotex Inc. Drugs for Treating Mental Disorders Product Offered
11.9.3 Apotex Inc. Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Apotex Inc. Main Business Overview
11.9.5 Apotex Inc. Latest Developments
11.10 Mylan Pharmaceuticals
11.10.1 Mylan Pharmaceuticals Company Information
11.10.2 Mylan Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
11.10.3 Mylan Pharmaceuticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Mylan Pharmaceuticals Main Business Overview
11.10.5 Mylan Pharmaceuticals Latest Developments
11.11 Par Pharmaceutical
11.11.1 Par Pharmaceutical Company Information
11.11.2 Par Pharmaceutical Drugs for Treating Mental Disorders Product Offered
11.11.3 Par Pharmaceutical Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Par Pharmaceutical Main Business Overview
11.11.5 Par Pharmaceutical Latest Developments
11.12 Aurobindo Pharma
11.12.1 Aurobindo Pharma Company Information
11.12.2 Aurobindo Pharma Drugs for Treating Mental Disorders Product Offered
11.12.3 Aurobindo Pharma Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Aurobindo Pharma Main Business Overview
11.12.5 Aurobindo Pharma Latest Developments
11.13 Torrent Pharmaceuticals
11.13.1 Torrent Pharmaceuticals Company Information
11.13.2 Torrent Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
11.13.3 Torrent Pharmaceuticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Torrent Pharmaceuticals Main Business Overview
11.13.5 Torrent Pharmaceuticals Latest Developments
11.14 Jubilant Lifesciences
11.14.1 Jubilant Lifesciences Company Information
11.14.2 Jubilant Lifesciences Drugs for Treating Mental Disorders Product Offered
11.14.3 Jubilant Lifesciences Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Jubilant Lifesciences Main Business Overview
11.14.5 Jubilant Lifesciences Latest Developments
11.15 Sun Pharmaceutical
11.15.1 Sun Pharmaceutical Company Information
11.15.2 Sun Pharmaceutical Drugs for Treating Mental Disorders Product Offered
11.15.3 Sun Pharmaceutical Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Sun Pharmaceutical Main Business Overview
11.15.5 Sun Pharmaceutical Latest Developments
11.16 Sandoz (Novartis)
11.16.1 Sandoz (Novartis) Company Information
11.16.2 Sandoz (Novartis) Drugs for Treating Mental Disorders Product Offered
11.16.3 Sandoz (Novartis) Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Sandoz (Novartis) Main Business Overview
11.16.5 Sandoz (Novartis) Latest Developments
11.17 Hansoh Pharmaceutical
11.17.1 Hansoh Pharmaceutical Company Information
11.17.2 Hansoh Pharmaceutical Drugs for Treating Mental Disorders Product Offered
11.17.3 Hansoh Pharmaceutical Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Hansoh Pharmaceutical Main Business Overview
11.17.5 Hansoh Pharmaceutical Latest Developments
11.18 WATSON Pharmaceuticals
11.18.1 WATSON Pharmaceuticals Company Information
11.18.2 WATSON Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
11.18.3 WATSON Pharmaceuticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 WATSON Pharmaceuticals Main Business Overview
11.18.5 WATSON Pharmaceuticals Latest Developments
11.19 Zhejiang Langhua Pharmaceuticals
11.19.1 Zhejiang Langhua Pharmaceuticals Company Information
11.19.2 Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
11.19.3 Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Zhejiang Langhua Pharmaceuticals Main Business Overview
11.19.5 Zhejiang Langhua Pharmaceuticals Latest Developments
11.20 Forest Laboratories
11.20.1 Forest Laboratories Company Information
11.20.2 Forest Laboratories Drugs for Treating Mental Disorders Product Offered
11.20.3 Forest Laboratories Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Forest Laboratories Main Business Overview
11.20.5 Forest Laboratories Latest Developments
11.21 H.Lundbeck A/S
11.21.1 H.Lundbeck A/S Company Information
11.21.2 H.Lundbeck A/S Drugs for Treating Mental Disorders Product Offered
11.21.3 H.Lundbeck A/S Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 H.Lundbeck A/S Main Business Overview
11.21.5 H.Lundbeck A/S Latest Developments
11.22 Amneal Pharmaceuticals
11.22.1 Amneal Pharmaceuticals Company Information
11.22.2 Amneal Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
11.22.3 Amneal Pharmaceuticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Amneal Pharmaceuticals Main Business Overview
11.22.5 Amneal Pharmaceuticals Latest Developments
11.23 Hetero Drugs
11.23.1 Hetero Drugs Company Information
11.23.2 Hetero Drugs Drugs for Treating Mental Disorders Product Offered
11.23.3 Hetero Drugs Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 Hetero Drugs Main Business Overview
11.23.5 Hetero Drugs Latest Developments
11.24 Macleods Pharmaceuticals
11.24.1 Macleods Pharmaceuticals Company Information
11.24.2 Macleods Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
11.24.3 Macleods Pharmaceuticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.24.4 Macleods Pharmaceuticals Main Business Overview
11.24.5 Macleods Pharmaceuticals Latest Developments
11.25 Silarx Pharmacueticals
11.25.1 Silarx Pharmacueticals Company Information
11.25.2 Silarx Pharmacueticals Drugs for Treating Mental Disorders Product Offered
11.25.3 Silarx Pharmacueticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.25.4 Silarx Pharmacueticals Main Business Overview
11.25.5 Silarx Pharmacueticals Latest Developments
11.26 Hikma Pharmaceuticals
11.26.1 Hikma Pharmaceuticals Company Information
11.26.2 Hikma Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
11.26.3 Hikma Pharmaceuticals Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.26.4 Hikma Pharmaceuticals Main Business Overview
11.26.5 Hikma Pharmaceuticals Latest Developments
11.27 Lupin Limited
11.27.1 Lupin Limited Company Information
11.27.2 Lupin Limited Drugs for Treating Mental Disorders Product Offered
11.27.3 Lupin Limited Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.27.4 Lupin Limited Main Business Overview
11.27.5 Lupin Limited Latest Developments
11.28 Prinston Pharmaceutical
11.28.1 Prinston Pharmaceutical Company Information
11.28.2 Prinston Pharmaceutical Drugs for Treating Mental Disorders Product Offered
11.28.3 Prinston Pharmaceutical Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.28.4 Prinston Pharmaceutical Main Business Overview
11.28.5 Prinston Pharmaceutical Latest Developments
11.29 STI Pharma
11.29.1 STI Pharma Company Information
11.29.2 STI Pharma Drugs for Treating Mental Disorders Product Offered
11.29.3 STI Pharma Drugs for Treating Mental Disorders Revenue, Gross Margin and Market Share (2020-2022)
11.29.4 STI Pharma Main Business Overview
11.29.5 STI Pharma Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Drugs for Treating Mental Disorders Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Tablets
Table 3. Major Players of Capsule
Table 4. Major Players of Injection
Table 5. Major Players of Solution
Table 6. Major Players of Other
Table 7. Drugs for Treating Mental Disorders Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Drugs for Treating Mental Disorders Market Size Market Share by Type (2017-2022)
Table 10. Drugs for Treating Mental Disorders Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Drugs for Treating Mental Disorders Market Size Market Share by Application (2017-2022)
Table 13. Global Drugs for Treating Mental Disorders Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Drugs for Treating Mental Disorders Revenue Market Share by Player (2020-2022)
Table 15. Drugs for Treating Mental Disorders Key Players Head office and Products Offered
Table 16. Drugs for Treating Mental Disorders Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Drugs for Treating Mental Disorders Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Drugs for Treating Mental Disorders Market Size Market Share by Regions (2017-2022)
Table 21. Americas Drugs for Treating Mental Disorders Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Drugs for Treating Mental Disorders Market Size Market Share by Country (2017-2022)
Table 23. Americas Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Drugs for Treating Mental Disorders Market Size Market Share by Type (2017-2022)
Table 25. Americas Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Drugs for Treating Mental Disorders Market Size Market Share by Application (2017-2022)
Table 27. APAC Drugs for Treating Mental Disorders Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Drugs for Treating Mental Disorders Market Size Market Share by Region (2017-2022)
Table 29. APAC Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Drugs for Treating Mental Disorders Market Size Market Share by Type (2017-2022)
Table 31. APAC Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Drugs for Treating Mental Disorders Market Size Market Share by Application (2017-2022)
Table 33. Europe Drugs for Treating Mental Disorders Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Drugs for Treating Mental Disorders Market Size Market Share by Country (2017-2022)
Table 35. Europe Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Drugs for Treating Mental Disorders Market Size Market Share by Type (2017-2022)
Table 37. Europe Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Drugs for Treating Mental Disorders Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Drugs for Treating Mental Disorders Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Drugs for Treating Mental Disorders Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Drugs for Treating Mental Disorders Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Drugs for Treating Mental Disorders Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Drugs for Treating Mental Disorders
Table 46. Key Market Challenges & Risks of Drugs for Treating Mental Disorders
Table 47. Key Industry Trends of Drugs for Treating Mental Disorders
Table 48. Global Drugs for Treating Mental Disorders Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Drugs for Treating Mental Disorders Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Drugs for Treating Mental Disorders Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Drugs for Treating Mental Disorders Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Drugs for Treating Mental Disorders Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Drugs for Treating Mental Disorders Market Size Market Share Forecast by Application (2023-2028)
Table 54. Johnson and Johnson Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 55. Johnson and Johnson Drugs for Treating Mental Disorders Product Offered
Table 56. Johnson and Johnson Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Johnson and Johnson Main Business
Table 58. Johnson and Johnson Latest Developments
Table 59. Pfizer Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 60. Pfizer Drugs for Treating Mental Disorders Product Offered
Table 61. Pfizer Main Business
Table 62. Pfizer Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Pfizer Latest Developments
Table 64. Eli Lilly Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 65. Eli Lilly Drugs for Treating Mental Disorders Product Offered
Table 66. Eli Lilly Main Business
Table 67. Eli Lilly Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Eli Lilly Latest Developments
Table 69. GlaxoSmithKline Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 70. GlaxoSmithKline Drugs for Treating Mental Disorders Product Offered
Table 71. GlaxoSmithKline Main Business
Table 72. GlaxoSmithKline Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. GlaxoSmithKline Latest Developments
Table 74. AstraZeneca Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 75. AstraZeneca Drugs for Treating Mental Disorders Product Offered
Table 76. AstraZeneca Main Business
Table 77. AstraZeneca Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. AstraZeneca Latest Developments
Table 79. Bristol-Myers Squibb Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 80. Bristol-Myers Squibb Drugs for Treating Mental Disorders Product Offered
Table 81. Bristol-Myers Squibb Main Business
Table 82. Bristol-Myers Squibb Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Bristol-Myers Squibb Latest Developments
Table 84. Teva Pharmaceutical Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 85. Teva Pharmaceutical Drugs for Treating Mental Disorders Product Offered
Table 86. Teva Pharmaceutical Main Business
Table 87. Teva Pharmaceutical Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Teva Pharmaceutical Latest Developments
Table 89. Dr. Reddy's Laboratories Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 90. Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Product Offered
Table 91. Dr. Reddy's Laboratories Main Business
Table 92. Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. Dr. Reddy's Laboratories Latest Developments
Table 94. Apotex Inc. Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 95. Apotex Inc. Drugs for Treating Mental Disorders Product Offered
Table 96. Apotex Inc. Main Business
Table 97. Apotex Inc. Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. Apotex Inc. Latest Developments
Table 99. Mylan Pharmaceuticals Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 100. Mylan Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
Table 101. Mylan Pharmaceuticals Main Business
Table 102. Mylan Pharmaceuticals Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Mylan Pharmaceuticals Latest Developments
Table 104. Par Pharmaceutical Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 105. Par Pharmaceutical Drugs for Treating Mental Disorders Product Offered
Table 106. Par Pharmaceutical Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 107. Par Pharmaceutical Main Business
Table 108. Par Pharmaceutical Latest Developments
Table 109. Aurobindo Pharma Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 110. Aurobindo Pharma Drugs for Treating Mental Disorders Product Offered
Table 111. Aurobindo Pharma Main Business
Table 112. Aurobindo Pharma Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 113. Aurobindo Pharma Latest Developments
Table 114. Torrent Pharmaceuticals Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 115. Torrent Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
Table 116. Torrent Pharmaceuticals Main Business
Table 117. Torrent Pharmaceuticals Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 118. Torrent Pharmaceuticals Latest Developments
Table 119. Jubilant Lifesciences Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 120. Jubilant Lifesciences Drugs for Treating Mental Disorders Product Offered
Table 121. Jubilant Lifesciences Main Business
Table 122. Jubilant Lifesciences Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 123. Jubilant Lifesciences Latest Developments
Table 124. Sun Pharmaceutical Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 125. Sun Pharmaceutical Drugs for Treating Mental Disorders Product Offered
Table 126. Sun Pharmaceutical Main Business
Table 127. Sun Pharmaceutical Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 128. Sun Pharmaceutical Latest Developments
Table 129. Sandoz (Novartis) Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 130. Sandoz (Novartis) Drugs for Treating Mental Disorders Product Offered
Table 131. Sandoz (Novartis) Main Business
Table 132. Sandoz (Novartis) Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 133. Sandoz (Novartis) Latest Developments
Table 134. Hansoh Pharmaceutical Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 135. Hansoh Pharmaceutical Drugs for Treating Mental Disorders Product Offered
Table 136. Hansoh Pharmaceutical Main Business
Table 137. Hansoh Pharmaceutical Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 138. Hansoh Pharmaceutical Latest Developments
Table 139. WATSON Pharmaceuticals Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 140. WATSON Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
Table 141. WATSON Pharmaceuticals Main Business
Table 142. WATSON Pharmaceuticals Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 143. WATSON Pharmaceuticals Latest Developments
Table 144. Zhejiang Langhua Pharmaceuticals Details, Company Type, Drugs for Treating Mental Disorders Area Served and Its Competitors
Table 145. Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Product Offered
Table 146. Zhejiang Langhua Pharmaceuticals Main Business
Table 147. Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 148. Zhejiang Langhua Pharmace
  • Global Medical Plasma Expressors Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 103
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Medical Plasma Expressors is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China marke......
  • Global Nasal Endoscopes Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 110
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Nasal Endoscopes is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China market for Nas......
  • Global Medical Ceiling Pendants Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 113
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Medical Ceiling Pendants is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China market......
  • Global Patient Remote Monitoring Systems Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 95
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Patient Remote Monitoring Systems estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Patient Remote Monitoring Systems is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through......
  • Global Disposable Intravenous Line Connectors Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 108
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Disposable Intravenous Line Connectors is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. Th......
  • Global Medical Ultrasound Machines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 129
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Medical Ultrasound Machines is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China mar......
  • Global Medical Thermoplastic Splints Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 131
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Medical Thermoplastic Splints is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China m......
  • Global Medical Disposable Isolation Gowns Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 114
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Medical Disposable Isolation Gowns is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The Ch......
  • Global Disposable Surgical Caps Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 126
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Disposable Surgical Caps is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China market......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs